Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CDC42
REST API REST API
Homo sapiens
CDC42 is differentially expressed in 325 experiments: 167 organism parts: kidney, liver, ... (165 more);, 260 disease states: normal, breast carcinoma, ... (258 more);, 106 cell types 466 cell lines 36 compound treatments and 78 other conditions.
Synonyms CDC42Hs, G25K
Orthologs CDC42 (Saccharomyces cerevisiae)   CDC42_CHICK (Gallus gallus)   F6R1X5_CIOIN (Ciona intestinalis)   ENSCING00000016916 (Ciona intestinalis)   Cdc42 (Rattus norvegicus)   cdc42 (Danio rerio)   F1MND1_BOVIN (Bos taurus)   Cdc42 (Mus musculus)   Cdc42 (Drosophila melanogaster)   cdc42 (Xenopus laevis)   (Compare orthologs)
Gene Ontology Term cytosol, spindle midzone, plasma membrane, cell division, negative regulation of epidermal growth factor receptor signaling pathway, stored secretory granule, GTPase activity, establishment or maintenance of cell polarity, adherens junction organization, protein binding, regulation of mitosis, regulation of protein catabolic process, cytoskeleton, cytoplasm, cell-cell adhesion, actin filament bundle assembly, epidermal growth factor receptor signaling pathway, intracellular, positive regulation of gene expression, membrane, establishment or maintenance of apical/basal cell polarity, Golgi membrane, epidermis morphogenesis, regulation of protein stability, regulation of protein kinase activity, nucleus localization, blood coagulation, nuclear migration, keratinization, positive regulation of JNK cascade, GTP catabolic process, multicellular organism growth, GTP binding, filopodium, actin cytoskeleton organization, axon guidance, regulation of protein metabolic process, small GTPase mediated signal transduction, midbody, microtubule organizing center, muscle cell differentiation, cell projection, filopodium assembly, regulation of small GTPase mediated signal transduction, canonical Wnt receptor signaling pathway, positive regulation of DNA replication, regulation of filopodium assembly, nucleotide binding, nervous system development, apical part of cell, negative regulation of gene expression, signal transduction, protein transport, GTP-dependent protein binding, epithelial cell-cell adhesion, positive regulation of peptidyl-serine phosphorylation, positive regulation of hair follicle cell proliferation, epithelial-mesenchymal cell signaling, hair follicle morphogenesis, positive regulation of pseudopodium assembly, neuron fate determination, regulation of protein heterodimerization activity, cellular protein localization, hair follicle placode formation, thioesterase binding, macrophage differentiation, keratinocyte development, T cell costimulation, positive regulation of MAPKKK cascade, positive regulation of muscle cell differentiation, regulation of attachment of spindle microtubules to kinetochore, mitogen-activated protein kinase kinase kinase binding, negative regulation of protein complex assembly, positive regulation of protein phosphorylation, cell periphery, positive regulation of phosphatidylinositol 3-kinase activity, positive regulation of cell cycle cytokinesis, mitotic spindle
InterPro Term MIRO-like, Small_GTPase, Small_GTP-bd_dom, Small_GTPase_ARF/SAR, Small_GTPase_Ras, Small_GTPase_Rho, Small_GTPase_Rab_type
UniProt Accession Q5JYX0, Q9UJM0, Q9UJM1, P60953, E7ETU3
Search EB-eye ENSG00000070831
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-GEOD-22541, E-GEOD-1577, E-GEOD-7540, ... (31 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-17482, E-GEOD-5258, E-GEOD-4525, E-MEXP-1006, E-GEOD-19639, ... (46 experiments)

Factor Value U/D Experiments
MCF-7
4
E-GEOD-5823, E-GEOD-3529, E-GEOD-20081, E-GEOD-19639
SW480
1
3
E-GEOD-18005, E-MTAB-37, E-GEOD-2509, E-MEXP-1014
UACC812
2
E-MTAB-62, E-MTAB-37
SNU1
2
E-MTAB-37, E-GEOD-15460
CCRFCEM
2
E-MTAB-37, E-GEOD-24147
LNCaP
2
E-GEOD-14990, E-GEOD-14464
460 more value(s).


Cell type

studied in E-GEOD-21668, E-GEOD-3920, E-MEXP-750, E-GEOD-20677, E-GEOD-21909, ... (49 experiments)

Factor Value U/D Experiments
CD19+ B cells (neg. sel.)
2
E-AFMX-5, E-TABM-145
CD56+ NK cells
2
E-AFMX-5, E-TABM-145
endothelial cell
2
E-GEOD-3920, E-GEOD-19240
testis - germ cell
2
E-AFMX-5, E-TABM-145
CXCR5(-)ICOS(-/lo) CD4 T cell
1
E-MEXP-750
CD16+ dendritic cell
1
E-TABM-34
100 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-15960, E-GEOD-2466, E-MEXP-1121, E-GEOD-1577, ... (70 experiments)

Factor Value U/D Experiments
glioblastoma
4
E-GEOD-4290, E-GEOD-6014, E-MTAB-62, E-GEOD-4412
cervical carcinoma
3
E-MTAB-62, E-MEXP-1331, E-GEOD-5823
lung adenocarcinoma
3
E-MTAB-62, E-MTAB-37, E-MEXP-231
septic shock
2
E-GEOD-8121, E-GEOD-9692
Duchenne muscular dystrophy
2
E-GEOD-3307, E-GEOD-1004
prostate carcinoma
2
E-MTAB-62, E-MEXP-2034
254 more value(s).


Compound treatment

studied in E-GEOD-5258, E-GEOD-5824, E-TABM-868, E-MEXP-1958, E-MEXP-2590, ... (27 experiments)

Factor Value U/D Experiments
control
3
E-GEOD-3284, E-GEOD-4006, E-GEOD-5339
none
5
6
E-GEOD-412, E-GEOD-5824, E-TABM-868, E-GEOD-995, E-GEOD-5099, ... (11 experiments)
interleukin-22 (Homo sapiens)
1
E-GEOD-7216
chloroguine
1
E-GEOD-5418
filtered air
1
E-TABM-127
actinomycin D
1
E-GEOD-6400
30 more value(s).


Agent

studied in E-GEOD-19519

Factor Value U/D Experiments
thapsigargin
1
E-GEOD-19519
tunicamycin
1
E-GEOD-19519


BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cancer site
studied in E-GEOD-4271

cd1a
studied in E-GEOD-22601

cd38
studied in E-GEOD-22601

Cell treatment
studied in E-MEXP-1192

Cellular component
studied in E-GEOD-1400

Clinical history
studied in E-GEOD-19420, E-GEOD-19743, E-GEOD-7967, E-GEOD-21374, E-GEOD-21589, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-6710, E-GEOD-19348, E-MEXP-1251, ... (9 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532, E-GEOD-1801, E-GEOD-21610

coriell cell line repository identifier
studied in E-GEOD-19519

development stage
studied in E-GEOD-22601

Developmental stage
studied in E-GEOD-19743, E-GEOD-20033, E-MEXP-2359, E-GEOD-6236, E-GEOD-4667, ... (7 experiments)

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-GEOD-22541, E-GEOD-2509, E-TABM-147, E-GEOD-21138, ... (7 experiments)

double amplification
studied in E-GEOD-22601

Environmental stress
studied in E-GEOD-1643, E-GEOD-1518, E-GEOD-4086

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MTAB-73, E-MEXP-1482, E-GEOD-7578, E-GEOD-20847, ... (9 experiments)

Genotype
studied in E-GEOD-2152, E-GEOD-17476, E-GEOD-2466, E-GEOD-22593, E-TABM-868, ... (17 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-5681, E-TABM-127, E-GEOD-20504, ... (10 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-2466, E-MEXP-2069, E-TABM-15, ... (41 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-2405, E-GEOD-12108

Initial distant metastases
studied in E-GEOD-22541

Injury
studied in E-GEOD-19743

Karyotype
studied in E-GEOD-7214

Labeling
studied in E-LGCL-5

Light
studied in E-GEOD-1725

Lymph node status
studied in E-GEOD-6532

Material type
studied in E-MEXP-455, E-MEXP-1082, E-GEOD-9171

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

organ
studied in E-GEOD-24283

Organism
studied in E-GEOD-7540, E-GEOD-1801, E-TABM-84

Organism status
studied in E-GEOD-19188

Original diagnosis
studied in E-GEOD-21521

P53 ihc
studied in E-GEOD-21653

Performer
studied in E-GEOD-2004, E-LGCL-5

Phenotype
studied in E-GEOD-19703, E-GEOD-22309, E-GEOD-21750, E-GEOD-6434, E-GEOD-1657, ... (7 experiments)

Population
studied in E-GEOD-4922, E-GEOD-4342

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-21837, E-GEOD-1880, E-GEOD-19445, E-GEOD-19246 ... (5 experiments)

pt
studied in E-GEOD-21653

Replicate
studied in E-GEOD-18791, E-GEOD-10896, E-GEOD-17204

RNAi
studied in E-MEXP-2115, E-GEOD-12438, E-MEXP-1509, E-GEOD-1676, E-MEXP-101, ... (9 experiments)

Sample preparation
studied in E-GEOD-16728

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374, E-MEXP-70, E-GEOD-17400, E-GEOD-18995 ... (5 experiments)

Sex
studied in E-GEOD-19069, E-GEOD-2466, E-GEOD-7307

Sirna
studied in E-GEOD-21574

Stimulation
studied in E-GEOD-4883, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Strain or line
studied in E-MEXP-1996, E-TABM-125

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-3494, E-GEOD-4922, E-GEOD-19188

targeted_cell_type
studied in E-MEXP-70

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

tissue (organ)
studied in E-GEOD-22601

Translocation cyclin group
studied in E-GEOD-2912

Treatment
studied in E-GEOD-16837, E-GEOD-19246, E-GEOD-13818, E-GEOD-19815, E-GEOD-15799, ... (6 experiments)

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-4290, E-GEOD-4271, E-GEOD-22541

Vehicle
studied in E-GEOD-5258

Processing time: 0.413 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM